レナサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/21 | 1,240 | 1,291 | 1,229 | 1,257 | +11 | +0.9% | 1,124,400 |
| 2025/03/19 | 1,087 | 1,403 | 1,087 | 1,246 | +130 | +11.6% | 6,861,800 |
| 2025/03/18 | 1,135 | 1,154 | 1,043 | 1,116 | -6 | -0.5% | 1,455,500 |
| 2025/03/17 | 1,002 | 1,122 | 990 | 1,122 | +150 | +15.4% | 744,800 |
| 2025/03/14 | 987 | 1,013 | 967 | 972 | -14 | -1.4% | 326,600 |
| 2025/03/13 | 1,003 | 1,030 | 981 | 986 | -14 | -1.4% | 341,500 |
| 2025/03/12 | 976 | 1,028 | 966 | 1,000 | +49 | +5.2% | 700,400 |
| 2025/03/11 | 983 | 990 | 917 | 951 | -55 | -5.5% | 771,400 |
| 2025/03/10 | 1,040 | 1,063 | 976 | 1,006 | -64 | -6% | 1,077,400 |
| 2025/03/07 | 1,151 | 1,152 | 1,041 | 1,070 | -109 | -9.2% | 879,900 |
| 2025/03/06 | 1,305 | 1,310 | 1,170 | 1,179 | -135 | -10.3% | 1,295,100 |
| 2025/03/05 | 1,206 | 1,327 | 1,187 | 1,314 | +83 | +6.7% | 926,000 |
| 2025/03/04 | 1,314 | 1,336 | 1,210 | 1,231 | -107 | -8% | 611,600 |
| 2025/03/03 | 1,247 | 1,370 | 1,215 | 1,338 | +102 | +8.3% | 614,500 |
| 2025/02/28 | 1,370 | 1,370 | 1,212 | 1,236 | -144 | -10.4% | 775,700 |
| 2025/02/27 | 1,451 | 1,460 | 1,345 | 1,380 | -119 | -7.9% | 995,000 |
| 2025/02/26 | 1,456 | 1,519 | 1,420 | 1,499 | +56 | +3.9% | 1,088,500 |
| 2025/02/25 | 1,323 | 1,450 | 1,321 | 1,443 | +116 | +8.7% | 905,900 |
| 2025/02/21 | 1,322 | 1,390 | 1,286 | 1,327 | +4 | +0.3% | 628,500 |
| 2025/02/20 | 1,334 | 1,358 | 1,286 | 1,323 | -1 | -0.1% | 540,400 |
| 2025/02/19 | 1,407 | 1,473 | 1,297 | 1,324 | -83 | -5.9% | 1,210,100 |
| 2025/02/18 | 1,427 | 1,579 | 1,375 | 1,407 | -21 | -1.5% | 2,065,800 |
| 2025/02/17 | 1,565 | 1,758 | 1,372 | 1,428 | -97 | -6.4% | 3,996,000 |
| 2025/02/14 | 1,299 | 1,525 | 1,291 | 1,525 | +300 | +24.5% | 2,191,900 |
| 2025/02/13 | 1,316 | 1,316 | 1,170 | 1,225 | -72 | -5.6% | 730,200 |
| 2025/02/12 | 1,187 | 1,390 | 1,165 | 1,297 | +99 | +8.3% | 1,918,000 |
| 2025/02/10 | 1,155 | 1,247 | 1,144 | 1,198 | -15 | -1.2% | 944,200 |
| 2025/02/07 | 1,200 | 1,310 | 1,150 | 1,213 | -36 | -2.9% | 1,305,200 |
| 2025/02/06 | 1,199 | 1,399 | 1,173 | 1,249 | +49 | +4.1% | 2,204,800 |
| 2025/02/05 | 1,391 | 1,393 | 1,180 | 1,200 | -177 | -12.9% | 1,650,500 |
| 2025/02/04 | 1,585 | 1,667 | 1,206 | 1,377 | -48 | -3.4% | 4,732,100 |
| 2025/02/03 | 1,080 | 1,425 | 1,056 | 1,425 | +300 | +26.7% | 6,346,900 |
| 2025/01/31 | 1,185 | 1,500 | 1,125 | 1,125 | -400 | -26.2% | 5,619,200 |
| 2025/01/30 | 2,375 | 2,474 | 1,525 | 1,525 | -500 | -24.7% | 2,092,900 |
| 2025/01/29 | 1,705 | 2,025 | 1,650 | 2,025 | +400 | +24.6% | 5,385,900 |
| 2025/01/28 | 1,355 | 1,625 | 1,355 | 1,625 | +300 | +22.6% | 5,434,100 |
| 2025/01/27 | 1,160 | 1,340 | 1,142 | 1,325 | +285 | +27.4% | 7,793,200 |
| 2025/01/24 | 944 | 1,040 | 935 | 1,040 | +150 | +16.9% | 2,316,100 |
| 2025/01/23 | 944 | 1,004 | 865 | 890 | +36 | +4.2% | 7,138,600 |
| 2025/01/22 | 726 | 854 | 705 | 854 | +150 | +21.3% | 3,961,700 |
| 2025/01/21 | 586 | 704 | 571 | 704 | +100 | +16.6% | 2,340,300 |
| 2025/01/20 | 610 | 624 | 552 | 604 | -7 | -1.1% | 1,846,600 |
| 2025/01/17 | 641 | 709 | 570 | 611 | -40 | -6.1% | 9,004,900 |
| 2025/01/16 | 531 | 651 | 502 | 651 | +100 | +18.1% | 8,587,300 |
| 2025/01/15 | 642 | 642 | 508 | 551 | +9 | +1.7% | 7,294,800 |
| 2025/01/14 | 477 | 542 | 434 | 542 | +80 | +17.3% | 6,179,800 |
| 2025/01/10 | 446 | 462 | 430 | 462 | +80 | +20.9% | 1,746,600 |
| 2025/01/09 | 382 | 382 | 382 | 382 | +80 | +26.5% | 54,100 |
| 2025/01/08 | 311 | 312 | 302 | 302 | -9 | -2.9% | 77,300 |
| 2025/01/07 | 310 | 311 | 296 | 311 | +12 | +4% | 214,400 |
101～
150
件表示中 / 954件
類似銘柄と比較する
現在ご覧いただいている「レナサイエンス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| レナサイエンス | 264,000円 | -14.4% | - | 0.00% | - | 19.51倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| 生化学 | 64,800円 | -9.6% | -30.2% | 4.63% | 26.21倍 | 0.48倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| 富士製薬 | 145,000円 | +15.7% | +5.3% | 3.14% | 10.48倍 | 0.77倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| ミズホメディ | 156,800円 | -20.7% | -41.2% | 6.06% | 13.36倍 | 1.73倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| アンジェス | 7,700円 | +110.0% | - | 0.00% | - | 8.29倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
市場注目の銘柄
チャート関連のコラム
